Purple Innovation Reports Fourth Quarter and Full Year 2021 Results; Board Names Robert DeMartini as Chief Executive Officer
Purple Innovation, Inc. (NASDAQ: PRPL) reported a 7.2% increase in Q4 2021 net revenue to $186.4 million, with wholesale revenue up 35.9% year-over-year. However, DTC revenue declined by 4.0%. The gross margin dropped to 34.7%, and operating loss was $(31.1) million. For the full year, net revenue reached $726.2 million, a 12.0% increase from 2020. Adjusted EBITDA stood at $(13.1) million. The company expects 2022 revenue between $790-$830 million and adjusted EBITDA between $26-$33 million. Rob DeMartini has been appointed permanent CEO, focusing on improving operations.
- Net revenue for Q4 2021 increased 7.2% year-over-year.
- Wholesale revenue rose by 35.9% compared to Q4 2020.
- Full year 2021 net revenue increased 12.0% to $726.2 million.
- 2022 revenue guidance of $790-$830 million indicates growth.
- DTC revenue declined 4.0% year-over-year in Q4 2021.
- Gross margin decreased to 34.7% from 47.2% in Q4 2020.
- Operating loss of $(31.1) million in Q4 2021 compared to operating income in 2020.
LEHI, Utah, March 1, 2022 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple"), a comfort innovation company known for creating the "World's First No Pressure® Mattress," today announced results for the fourth quarter and year ended December 31, 2021. The Company also announced that its Board of Directors has appointed Robert DeMartini Chief Executive Officer, effective upon finalization of an amended and restated employment agreement. DeMartini was appointed Acting Chief Executive Officer in December 2021.
Fourth Quarter Financial Summary (Comparisons versus Fourth Quarter 2020 and 2019)1
- Net revenue increased
7.2% to$186.4 million , compared to 2020 and increased50.0% compared to 2019. - Wholesale revenue increased
35.9% over 2020 and48.7% over 2019; Direct-to-Consumer (DTC) revenue decreased4.0% compared to 2020 and increased50.7% over 2019. - Gross margin was
34.7% compared to47.2% in 2020 and47.7% in 2019. - Operating expenses as a percent of net revenue were
51.4% compared to42.9% in 2020 and45.4% in 2019. - Operating loss was
$(31.1) million compared to operating income of$7.5 million in 2020 and operating income of$2.8 million 2019. - Net loss was
$(21.8) million compared to a net loss of$(73.5) million in 2020 and a net loss of$(26.2) million in 2019. Adjusted net loss was$(23.9) million , or$(0.35) per diluted share, as compared to adjusted net income of$5.0 million , or$0.07 per diluted share, in 2020 and adjusted net income of$1.2 million , or$0.02 per diluted share, in 2019. - EBITDA was
$(20.0) million compared to$(79.1) million in 2020 and$(22.8) million in 2019, reflecting primarily the impact from the change in fair value of warrant liabilities. Adjusted EBITDA was$(23.4) million compared to$12.2 million in 2020 and$5.8 million in 2019.
Full Year 2021 Financial Summary (Comparisons versus Full Year 2020 and 2019)1
- Net revenue increased
12.0% to$726.2 million , compared to 2020 and increased69.5% compared to 2019. - Wholesale revenue increased
54.5% over 2020 and 2019; Direct-to-Consumer (DTC) revenue decreased2.3% compared to 2020 and increased78.8% over 2019. - Gross margin was
40.6% compared to47.0% in 2020 and44.1% in 2019. - Operating expenses as a percent of net revenue were
43.8% compared to36.1% in 2020 and40.3% in 2019. - Operating loss was
$(23.4) million compared to operating income of$71.2 million in 2020 and operating income of$16.2 million 2019. - Net income was
$3.9 million compared to a net loss of$(229.8) million in 2020 and a net loss of ($30.9) million in 2019. Adjusted net loss was$(13.1) million , or$(0.19) per diluted share, as compared to adjusted net income of$49.5 million , or$0.78 per diluted share, in 2020 and adjusted net income of$15.9 million , or$0.29 per diluted share, in 2019. - EBITDA was
$14.2 million compared to$(260.9) million in 2020 and$(21.6) million in 2019, reflecting primarily the impact from the change in fair value of warrant liabilities. Adjusted EBITDA was$11.0 million compared to$88.1 million in 2020 and$33.4 million in 2019.
The Company views comparison to the 2019 period to be more meaningful than the comparable 2020 period given the exceptional COVID-19 related consumer demand changes experienced in the same period in 2020.
"I am very excited to be leading Purple during this important period in the Company's history," said Chief Executive Officer Rob DeMartini. "Purple has established itself as a differentiated premium mattress brand through proprietary comfort technologies that provide consumers with a superior sleeping experience. Following several years of hyper growth and increased investments to support current and future expansion, we are now focusing on right-sizing our operations, improving our execution and refining our strategies to drive profitable growth in the current market environment. This work is already underway and we are making good progress but we are still in the early stages of building the framework for strong operational maturity and accountability. Since joining Purple, I have been continually impressed by the passion and commitment exhibited throughout the organization and the wealth of experience across our teams particularly in research and development. The foundation that is in place is adding to my conviction in this business and my confidence in our ability to achieve our near- and long-term objectives."
Chief Executive Officer Appointment
Paul Zepf, Chairman of the Purple Board of Directors, said, "We are very pleased to have Rob as our permanent CEO. Our search process was exhaustive, and Rob's experience, leadership, and focus on execution made him the obvious choice to lead Purple to its next phase of success. His demonstrated leadership in developing our go forward execution-oriented strategy over the past couple of months allows the Company to move forward quickly."
Rob DeMartini is an experienced leader with a long history of strong growth and execution during his 37-year career. Mr. DeMartini served as President and Chief Executive Officer of New Balance from 2007 to 2019. During his twelve-year tenure, New Balance increased its annual sales to over
Fourth Quarter 2021 Review
Fourth quarter 2021 net revenue increased
Gross margin for the fourth quarter 2021 was
Operating expenses were
Operating loss was
Net loss was
Adjusted net loss was
EBITDA for the fourth quarter 2021 was
Full Year 2021 Review
Full year 2021 net revenue increased
Gross margin for the full year 2021 was
Operating expenses were
Operating loss was
Net income for 2021 was
Adjusted net loss was
EBITDA for 2021 was
Balance Sheet
As of December 31, 2021, the Company had cash and cash equivalents of
Outlook
For 2022, the Company currently expects full year revenue to be in the range of
For the first quarter of 2022, the Company currently expects revenue to be in the range of
Based on its current outlook and planned uses of cash, the Company expects its liquidity at the end of the first quarter to be between
Conference Call and Webcast Information
Purple Innovation, Inc. will host a live conference call to discuss financial results on March 1, 2022 at 4:30 p.m. Eastern Time. To access the call dial (877) 425-9470 (domestic) or (201) 389-0878 (international) and provide the Conference ID: 13727213. The call is also being webcast and can be accessed on the investor relations section of the Company's website, investors.purple.com. After the conference call, a webcast replay will remain available on the investor relations section of the Company's website for 30 days.
About Purple
Purple is a digitally-native vertical brand with a mission to help people feel and live better through innovative comfort solutions. We design and manufacture a variety of innovative, premium, branded comfort products, including mattresses, pillows, cushions, frames, sheets and more. Our products are the result of over 30 years of innovation and investment in proprietary and patented comfort technologies and the development of our own manufacturing processes. Our proprietary gel technology, Hyper-Elastic Polymer®, underpins many of our comfort products and provides a range of benefits that differentiate our offerings from other competitors' products. We market and sell our products through our direct-to-consumer online channels, traditional retail partners, third-party online retailers and our owned retail showrooms. For more information on Purple, visit purple.com.
Forward Looking Statements
Certain statements made in this release that are not historical facts are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements include but are not limited to statements relating to the timing and extent of expected future growth of revenue and earnings and anticipated growth rates; the impact on our business of our efforts to right-size our operations, improve execution, and drive profitable growth; demand for our products; expectations regarding consumer behavior; the impact of our marketing efforts on our business; our ability to gain market share; our ability to expand our physical presence through partner and owned retail stores; expected improvements in our operations and financial results and the timing of such improvements; expectations regarding sequential improvements in our performance; and expected financial and operating results, including liquidity, for the first quarter of 2022 and full year 2022. Statements based on historical data are not intended and should not be understood to indicate the Company's expectations regarding future events. Forward-looking statements provide current expectations or forecasts of future events or determinations. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Factors that could influence the realization of forward-looking statements include, among others: uncertainties regarding the extent and duration of the impact of the COVID-19 pandemic and supply chain issues on many aspects of our business, operations and financial performance; disruptions to our manufacturing processes; changes in economic, financial and end-market conditions in the markets in which we operate; fluctuations in shipping, raw material and labor prices; demand in our wholesale and DTC channels being lower than anticipated; our inability to execute on strategies to expand our wholesale channel; material changes in our relationships with wholesale partners; the financial condition of our customers and suppliers; competitive pressures, including the need for technology improvement, successful new product development and introduction; and the risk factors outlined in the "Risk Factors" section of our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on March 1, 2022. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Non-GAAP Financial Measures
EBITDA, adjusted EBITDA, adjusted net income, and adjusted net income per diluted share are non-GAAP financial measures that remove the impact of certain non-cash and non-recurring costs. Management believes that the use of such non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. Refer to the attached table for the reconciliation of such non-GAAP financial measures to the most comparable GAAP financial measure.
With respect to the Company's Adjusted EBITDA outlook for the first quarter and full year 2022, a quantitative reconciliation to the corresponding GAAP information cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including but not limited to warrant liabilities and stock based compensation. For the same reasons, the Company is unable to assess the probable significance of the unavailable information, which could have a material impact on its future GAAP financial results.
Investor Contact:
Brendon Frey, ICR
brendon.frey@icrinc.com
203-682-8200
Purple Innovation, Inc.
Misty Bond
Director of Purple Communications
misty.b@purple.com
385-498-1851
1 Reconciliations for non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the "RECONCILIATION OF GAAP TO NON-GAAP MEASURES" tables at the end of this press release.
PURPLE INNOVATION, INC. | ||||||||
Condensed Consolidated Balance Sheets | ||||||||
(unaudited – in thousands, except par value) | ||||||||
December 31, | December 31, | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 91,616 | $ | 122,955 | ||||
Accounts receivable, net | 25,430 | 29,111 | ||||||
Inventories, net | 98,690 | 65,726 | ||||||
Prepaid inventory | 8,064 | 826 | ||||||
Other current assets | 5,702 | 10,453 | ||||||
Total current assets | 229,502 | 229,071 | ||||||
Property and equipment, net | 112,614 | 61,486 | ||||||
Operating lease right-of-use assets | 68,037 | 41,408 | ||||||
Intangible assets, net | 13,204 | 9,945 | ||||||
Deferred income taxes | 217,791 | 211,244 | ||||||
Other long-term assets | 1,322 | 1,578 | ||||||
Total assets | $ | 642,470 | $ | 554,732 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 79,752 | $ | 69,594 | ||||
Accrued sales returns | 7,116 | 8,428 | ||||||
Accrued compensation | 8,928 | 14,209 | ||||||
Customer prepayments | 10,854 | 6,253 | ||||||
Accrued sales tax | 4,672 | 6,015 | ||||||
Accrued rebates and allowances | 10,169 | 10,891 | ||||||
Operating lease obligations – current portion | 7,053 | 3,235 | ||||||
Other current liabilities | 13,470 | 13,583 | ||||||
Total current liabilities | 142,014 | 132,208 | ||||||
Debt, net of current portion | 94,113 | 41,410 | ||||||
Operating lease obligations, net of current portion | 81,159 | 48,936 | ||||||
Warrant liabilities | 4,343 | 92,708 | ||||||
Tax receivable agreement liability, net of current portion | 162,239 | 165,426 | ||||||
Other long-term liabilities, net of current portion | 12,061 | 6,503 | ||||||
Total liabilities | 495,929 | 487,191 | ||||||
Commitments and contingencies (Note 12) | ||||||||
Stockholders' equity: | ||||||||
Class A common stock; | 7 | 6 | ||||||
Class B common stock; | — | — | ||||||
Additional paid-in capital | 407,591 | 333,047 | ||||||
Accumulated deficit | (261,825) | (265,856) | ||||||
Total stockholders' equity | 145,773 | 67,197 | ||||||
Noncontrolling interest | 768 | 344 | ||||||
Total stockholders' equity | 146,541 | 67,541 | ||||||
Total liabilities and stockholders' equity | $ | 642,470 | $ | 554,732 |
PURPLE INNOVATION, INC. | ||||||||||||||||||||||||
Condensed Consolidated Statements of Operations | ||||||||||||||||||||||||
(unaudited – in thousands, except per share amounts) | ||||||||||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||||||||||
2021 | 2020 | 2019 | 2021 | 2020 | 2019 | |||||||||||||||||||
Revenues, net | $ | 186,431 | $ | 173,889 | $ | 124,300 | $ | 726,227 | $ | 648,471 | $ | 428,358 | ||||||||||||
Cost of revenues | 121,748 | 91,859 | 65,064 | 431,253 | 343,374 | 239,387 | ||||||||||||||||||
Gross profit | 64,683 | 82,030 | 59,236 | 294,974 | 305,097 | 188,971 | ||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||
Marketing and sales | 76,237 | 60,678 | 47,936 | 239,290 | 187,991 | 141,975 | ||||||||||||||||||
General and administrative | 18,071 | 12,613 | 7,675 | 72,095 | 39,925 | 26,918 | ||||||||||||||||||
Research and development | 1,509 | 1,243 | 860 | 6,939 | 5,955 | 3,864 | ||||||||||||||||||
Total operating expenses | 95,817 | 74,534 | 56,471 | 318,324 | 233,871 | 172,757 | ||||||||||||||||||
Operating income (loss) | (31,134) | 7,496 | 2,765 | (23,350) | 71,226 | 16,214 | ||||||||||||||||||
Other income (expense): | ||||||||||||||||||||||||
Interest expense | (743) | (609) | (1,379) | (1,872) | (4,654) | (5,180) | ||||||||||||||||||
Other income (expense), net | (164) | (200) | 172 | (194) | (91) | 545 | ||||||||||||||||||
Loss on extinguishment of debt | — | — | — | — | (5,782) | (6,299) | ||||||||||||||||||
Change in fair value – warrant liabilities | 4,685 | (87,480) | (26,889) | 24,054 | (300,073) | (35,304) | ||||||||||||||||||
Tax receivable agreement income (expense) | 3,377 | (643) | (501) | 4,016 | (34,155) | (501) | ||||||||||||||||||
Total other income (expense), net | 7,155 | (88,932) | (28,597) | 26,004 | (344,755) | (46,739) | ||||||||||||||||||
Net income (loss) before income taxes | (23,979) | (81,436) | (25,832) | 2,654 | (273,529) | (30,525) | ||||||||||||||||||
Income tax benefit (expense) | 2,222 | 7,931 | (400) | 1,217 | 43,749 | (400) | ||||||||||||||||||
Net income (loss) | (21,757) | (73,505) | (26,232) | 3,871 | (229,780) | (30,925) | ||||||||||||||||||
Net income (loss) attributable | (215) | (91) | (8,576) | (160) | 7,087 | (8,352) | ||||||||||||||||||
Net income (loss) attributable to | $ | (21,542) | $ | (73,414) | (17,656) | $ | 4,031 | $ | (236,867) | (22,573) | ||||||||||||||
Net income (loss) per share: | ||||||||||||||||||||||||
Basic | $ | (0.32) | $ | (1.22) | $ | (1.24) | $ | 0.06 | $ | (6.04) | $ | (2.26) | ||||||||||||
Diluted | $ | (0.39) | $ | (1.22) | $ | (1.24) | $ | (0.30) | $ | (6.04) | $ | (2.26) | ||||||||||||
Weighted average common | ||||||||||||||||||||||||
Basic | 66,483 | 60,372 | 14,242 | 65,928 | 39,219 | 10,006 | ||||||||||||||||||
Diluted | 67,302 | 60,372 | 14,242 | 67,302 | 39,219 | 10,006 |
PURPLE INNOVATION, INC. | |||||||||||||||||||||||||
Condensed Consolidated Statements of Cash Flows | |||||||||||||||||||||||||
(unaudited – in thousands) | |||||||||||||||||||||||||
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||||||||||||
2021 | 2020 | 2019 | 2021 | 2020 | 2019 | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||||||
Net income (loss) | $ | (21,757) | $ | (73,505) | $ | (26,232) | $ | 3,871 | $ | (229,780) | $ | (30,925) | |||||||||||||
Adjustments to reconcile net | |||||||||||||||||||||||||
Depreciation and amortization | 3,118 | 1,533 | 1,816 | 9,473 | 7,899 | 4,308 | |||||||||||||||||||
Non-cash interest | 129 | 132 | 874 | 517 | 3,105 | 3,313 | |||||||||||||||||||
Paid-in-kind interest | — | — | — | — | (6,616) | — | |||||||||||||||||||
Loss on extinguishment of debt | — | — | — | — | 5,782 | 6,299 | |||||||||||||||||||
Change in fair value – warrant liabilities | (4,685) | 87,480 | 26,889 | (24,054) | 300,073 | 35,304 | |||||||||||||||||||
Tax receivable agreement (income) expense | (3,377) | 643 | 501 | (4,016) | 34,155 | 501 | |||||||||||||||||||
Stock-based compensation | 1,009 | 626 | 323 | 3,366 | 2,185 | 10,063 | |||||||||||||||||||
Non-cash lease expense | 1,577 | 918 | — | 4,938 | 3,128 | — | |||||||||||||||||||
Deferred income taxes | (1,871) | (9,994) | — | (3,608) | (45,812) | — | |||||||||||||||||||
Changes in operating assets and liabilities: | |||||||||||||||||||||||||
Accounts receivable | 2,140 | (7,217) | (2,005) | 3,681 | (419) | (18,451) | |||||||||||||||||||
Inventories | (14,645) | (14,951) | (12,810) | (32,964) | (18,098) | (24,688) | |||||||||||||||||||
Prepaid expenses and other assets | (633) | 693 | 378 | 1,536 | (5,047) | (2,557) | |||||||||||||||||||
Accounts payable | 8,995 | 6,371 | 14,030 | 6,796 | 16,049 | 25,132 | |||||||||||||||||||
Accrued sales returns | 213 | (1,857) | 1,977 | (1,312) | 1,157 | 1,814 | |||||||||||||||||||
Accrued compensation | (4,665) | 1,694 | 2,433 | (5,482) | 6,255 | 5,263 | |||||||||||||||||||
Customer prepayments | 1,571 | 46 | (1,434) | 4,601 | (5) | (1,264) | |||||||||||||||||||
Accrued rebates and allowances | 2,098 | (1,921) | — | (722) | 5,580 | 4,881 | |||||||||||||||||||
Operating lease obligations | (955) | (458) | — | (2,779) | (1,732) | — | |||||||||||||||||||
Other accrued liabilities | 703 | 3,624 | 296 | 5,255 | 3,398 | 3,887 | |||||||||||||||||||
Net cash provided by (used in) operating activities | (31,035) | (6,143) | 7,036 | (30,903) | 81,257 | 22,880 | |||||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||||||
Purchase of property and equipment | (13,792) | (13,684) | (4,802) | (53,938) | (27,878) | (10,459) | |||||||||||||||||||
Investment in intangible assets | (1,769) | (371) | (74) | (3,121) | (11,261) | (320) | |||||||||||||||||||
Net cash used in investing activities | (15,561) | (14,055) | (4,876) | (57,059) | (39,139) | (10,779) | |||||||||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||||||
Proceeds from related-party loan | — | — | — | — | — | 10,000 | |||||||||||||||||||
Proceeds from term loan | — | — | — | — | 45,000 | — | |||||||||||||||||||
Payments on related-party loan | — | — | — | — | (37,497) | — | |||||||||||||||||||
Payments on term loan | (562) | (563) | — | (2,250) | (563) | — | |||||||||||||||||||
Proceeds from revolving line of credit | 55,000 | — | — | 55,000 | — | — | |||||||||||||||||||
Proceeds from exercise of warrants | — | 45,653 | — | 116 | 46,359 | — | |||||||||||||||||||
Proceeds from exercise of stock options | 376 | 589 | 1,418 | 2,007 | — | ||||||||||||||||||||
Repurchase of stock options | — | — | — | — | — | (97) | |||||||||||||||||||
Payments for debt issuance costs | — | — | — | — | (2,460) | (758) | |||||||||||||||||||
Tax receivable agreement payments | — | — | — | (628) | — | — | |||||||||||||||||||
Proceeds from InnoHold indemnification payment | — | — | — | 4,142 | — | — | |||||||||||||||||||
Principal payments on capital lease obligations | 25 | ||||||||||||||||||||||||
Distributions to members | (218) | (481) | (1,175) | (5,487) | — | ||||||||||||||||||||
Net cash provided by financing activities | 54,596 | 45,198 | 25 | 56,623 | 47,359 | 9,145 | |||||||||||||||||||
Net increase (decrease) in cash | 8,000 | 25,000 | 2,185 | (31,339) | 89,477 | 21,246 | |||||||||||||||||||
Cash and cash equivalents, beginning of the year | 83,616 | 97,955 | 31,293 | 122,955 | 33,478 | 12,232 | |||||||||||||||||||
Cash and cash equivalents, end of the year | $ | 91,616 | $ | 122,955 | 33,478 | $ | 91,616 | $ | 122,955 | $ | 33,478 | ||||||||||||||
Supplemental disclosures of cash flow information: | |||||||||||||||||||||||||
Cash paid during the year for interest, | $ | 610 | $ | 8,167 | 505 | $ | 999 | $ | 8,167 | $ | 1,869 | ||||||||||||||
Cash paid during the year for income taxes | $ | 60 | $ | 2,060 | 122 | $ | 4,555 | $ | 2,060 | $ | 122 | ||||||||||||||
Supplemental schedule of non-cash investing | |||||||||||||||||||||||||
Property and equipment included in | $ | 736 | $ | 3,305 | 588 | $ | 6,443 | $ | 3,305 | $ | 743 | ||||||||||||||
Issuance of liability warrants | — | — | — | — | $ | — | $ | 4,864 | |||||||||||||||||
Non-cash leasehold improvements | $ | — | $ | 5,147 | 1,938 | $ | 3,238 | $ | 5,147 | $ | 1,938 | ||||||||||||||
Accrued tax distributions | $ | 97 | $ | — | — | $ | 401 | $ | 668 | $ | 308 | ||||||||||||||
Tax receivable agreement liability | $ | — | $ | 137,314 | — | $ | 776 | $ | 137,314 | $ | — | ||||||||||||||
Deferred income taxes | $ | 1,984 | $ | 165,676 | — | $ | 2,953 | $ | 165,676 | $ | — | ||||||||||||||
Exercise of liability warrants | $ | (10) | $ | 252,796 | — | $ | 64,311 | $ | 252,796 | $ | — | ||||||||||||||
PURPLE INNOVATION, INC.
RECONCILIATION OF GAAP TO NON-GAAP MEASURES
(In thousands)
Management believes that the use of the following non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. These non-GAAP financial measures are EBITDA, adjusted EBITDA, adjusted net income, and adjusted net income per diluted share. Other companies may calculate these non-GAAP measures differently than we do. These non-GAAP measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for our financial results prepared in accordance with GAAP.
Reconciliation of GAAP Net Income (Loss) to Non-GAAP EBITDA and Adjusted EBITDA
A reconciliation of GAAP net income (loss) to the non-GAAP measures of EBITDA and adjusted EBITDA is provided below. EBITDA represents net income (loss) before interest expense, income tax (benefit) expense, other (income) expense, net, and depreciation and amortization. Adjusted EBITDA represents EBITDA excluding costs incurred due to stock-based compensation expense, product reserve, debt extinguishment, changes in the fair value of the warrant liability, nonrecurring legal fees, executive interim and search costs, severance costs, vendor impairment, intangible asset adjustment, showroom opening costs, new production facility start-up costs, previous period sales tax liability and COVID-19 related expenses. We believe EBITDA and Adjusted EBITDA provide additional useful information with respect to the impact of various adjustments and provide meaningful measures of our operating performance.
Three Months Ended December 31, | Year Ended December 31, | |||||||||||||||||||||||
2021 | 2020(1) | 2019(1) | 2021 | 2020(1) | 2019(1) | |||||||||||||||||||
GAAP net income (loss) | $ | (21,757) | $ | (73,505) | $ | (26,232) | $ | 3,871 | $ | (229,780) | $ | (30,925) | ||||||||||||
Interest (income) expense | 743 | 609 | 1,379 | 1,872 | 4,654 | 5,180 | ||||||||||||||||||
Income tax (benefit) expense | (2,222) | (7,931) | 400 | (1,217) | (43,749) | 400 | ||||||||||||||||||
Other income (expense), net | 164 | 200 | (172) | 194 | 91 | (545) | ||||||||||||||||||
Depreciation and amortization | 3,118 | 1,533 | 1,816 | 9,473 | 7,899 | 4,308 | ||||||||||||||||||
EBITDA | (19,955) | (79,094) | (22,809) | 14,193 | (260,885) | (21,582) | ||||||||||||||||||
Adjustments: | ||||||||||||||||||||||||
Debt extinguishment and | (4,685) | 87,480 | 26,889 | (24,054) | 305,855 | 41,603 | ||||||||||||||||||
Stock-based compensation expense | 1,009 | 626 | 323 | 3,366 | 2,185 | 10,063 | ||||||||||||||||||
Product reserve | — | — | — | — | 500 | — | ||||||||||||||||||
Tax receivable agreement | (3,377) | 643 | 501 | (4,016) | 34,155 | 501 | ||||||||||||||||||
Nonrecurring legal fees | 163 | 488 | 390 | 10,044 | 1,544 | 809 | ||||||||||||||||||
Executive interim and search costs | 980 | 126 | 30 | 3,146 | 126 | 706 | ||||||||||||||||||
Severance costs | 1,304 | 70 | 30 | 1,897 | 203 | 730 | ||||||||||||||||||
Vendor impairment | — | — | — | — | 1,660 | — | ||||||||||||||||||
Intangible asset adjustment | — | — | 404 | — | — | 404 | ||||||||||||||||||
Showroom opening costs | 763 | 222 | — | 1,945 | 222 | — | ||||||||||||||||||
New production facility start-up costs | 275 | 1,237 | — | 3,131 | 1,237 | — | ||||||||||||||||||
Previous period sales tax liability | — | 322 | — | 1,049 | 1,011 | 200 | ||||||||||||||||||
COVID-19 related expenses | 122 | 104 | — | 263 | 311 | — | ||||||||||||||||||
Adjusted EBITDA | $ | (23,400) | $ | 12,224 | $ | 5,758 | $ | 10,964 | $ | 88,124 | $ | 33,434 |
(1) | Reflects the effect of the previously disclosed restatement due to the outstanding warrants being accounted for as liabilities and recorded at fair value. |
Reconciliation of GAAP Net Income to non-GAAP Adjusted Net Income and Adjusted Net Income per Diluted Share
Our presentation of adjusted net income assumes that all net income is attributable to Purple Innovation, Inc. (i.e. there is no allocation of net income or loss to noncontrolling interests), which assumes the full exchange at the beginning of the period of all outstanding Paired Securities for shares of Class A common stock of Purple Innovation, Inc., adjusted for certain nonrecurring items that we do not believe directly reflect our core operations. Adjusted net income per share, diluted, is calculated by dividing adjusted net income by the total shares of Class A common stock outstanding plus any dilutive warrants, options and restricted stock as calculated in accordance with GAAP and assuming the full exchange of all outstanding Paired Securities as of the beginning of each period presented. Adjusted net income and adjusted net income per diluted share, are supplemental measures of operating performance that do not represent, and should not be considered, alternatives to net income and earnings per share, as calculated in accordance with GAAP. We believe adjusted net income and adjusted net income per diluted share, supplement GAAP measures and enable us to more effectively evaluate our performance period-over-period. A reconciliation of net income (loss), the most directly comparable GAAP measure, to adjusted net income and the computation of adjusted net income per diluted share, are set forth below:
(in thousands, except per share amounts) | Three Months Ended | Year Ended | |||||||||||||||||||||||||
2021 | 2020(1) | 2019(1) | 2021 | 2020(1) | 2019(1) | ||||||||||||||||||||||
Net income (loss) | $ | (21,757) | $ | (73,505) | $ | (26,232) | |||||||||||||||||||||
Income tax (benefit) expense, as reported | (2,222) | (7,931) | 400 | (1,217) | (43,749) | 400 | |||||||||||||||||||||
Tax receivable agreement (income) expense | (3,377) | 643 | 501 | (4,016) | 34,155 | 501 | |||||||||||||||||||||
Change in fair value – warrant liabilities | (4,685) | 87,480 | 26,889 | (24,054) | 300,073 | 35,304 | |||||||||||||||||||||
Stock-based compensation(2) | — | — | — | — | — | 9,740 | |||||||||||||||||||||
Loss on extinguishment of debt | — | — | — | — | 5,782 | 6,299 | |||||||||||||||||||||
Secondary offering expenses | — | — | — | 7,858 | — | — | |||||||||||||||||||||
Adjusted net income (loss) before income taxes | (32,041) | 6,687 | 1,558 | (17,558) | 66,481 | 21,319 | |||||||||||||||||||||
Adjusted income taxes(3) | 8,138 | (1,712) | (399) | 4,460 | (17,019) | (5,458) | |||||||||||||||||||||
Adjusted net income (loss) | $ | (23,903) | 4,975 | 1,159 | (13,098) | 49,462 | 15,861 | ||||||||||||||||||||
Adjusted net income (loss) per share, diluted | $ | (0.35) | $ | 0.07 | $ | 0.02 | $ | (0.19) | $ | 0.78 | $ | 0.29 | |||||||||||||||
Adjusted weighted-average shares | 67,454 | 68,582 | 55,451 | 67,302 | 63,572 | 54,977 | |||||||||||||||||||||
(1) | Reflects the effect of the previously disclosed restatement due to the outstanding warrants being accounted for as liabilities and recorded at fair value. |
(2) | Reflects the stock-based compensation related to the InnoHold Incentive Units issued in 2019. |
(3) | Represents the estimated effective tax rate of |
(4) | Assumes dilutive warrants, options and restricted stock calculated in accordance with GAAP and the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period. |
A reconciliation of net income (loss) per share, diluted, to adjusted net income per diluted share is set forth below for the three and nine months ended September 30, 2021, 2020 and 2019:
For the Three Months Ended | ||||||||||||||||||||||||||||||||||||
December 31, 2021 | December 31, 2020(1) | December 31, 2019(1) | ||||||||||||||||||||||||||||||||||
Net | Weighted | Net | Net | Weighted | Net | Net | Weighted | Net | ||||||||||||||||||||||||||||
Net income (loss) attributable to | $ | (21,542) | 66,483 | $ | (0.32) | $ | (73,414) | 60,372 | $ | (1.22) | $ | (17,656) | 14,242 | $ | (1.24) | |||||||||||||||||||||
Assumed exchange of shares(3) | (215) | 448 | (91) | 574 | (8,576) | 38,263 | ||||||||||||||||||||||||||||||
Net income (loss) | (21,757) | (73,505) | (26,232) | |||||||||||||||||||||||||||||||||
Adjustments to arrive at adjusted | (10,284) | 523 | 80,192 | 7,636 | 27,790 | 2,946 | ||||||||||||||||||||||||||||||
Adjusted net income (loss) before taxes | (32,041) | 6,687 | 1,159 | |||||||||||||||||||||||||||||||||
Adjusted income taxes(5) | 8,138 | (1,712) | (399) | |||||||||||||||||||||||||||||||||
Adjusted net income (loss) | $ | (23,903) | 67,454 | $ | (0.35) | $ | 4,975 | 68,582 | $ | 0.07 | $ | 1,159 | 55,451 | $ | 0.02 |
(1) | Reflects the effect of the previously disclosed restatement due to the outstanding warrants being accounted for as liabilities and recorded at fair value. |
(2) | Represents net income attributable to Purple Innovation, Inc. and the associated weighted average diluted shares, of Class A common stock outstanding. |
(3) | Assumes the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period. Also assumes the addition of net income attributable to noncontrolling interests corresponding with the assumed exchange of the Paired Securities for shares of Class A common stock. |
(4) | Represents the total impact of all adjustments identified in the adjusted net income table above to arrive at adjusted income before income taxes. Also assumes the dilutive warrants, options and restricted stock as calculated in accordance with GAAP. |
(5) | Represents the estimated effective tax rate of |
For the Year Ended | |||||||||||||||||||||||||||||||||||||
December 31, 2021 | December 31, 2020(1) | December 31, 2019(1) | |||||||||||||||||||||||||||||||||||
Net | Weighted | Net | Net | Weighted | Net | Net | Weighted | Net | |||||||||||||||||||||||||||||
Net income (loss) attributable to | $ | 4,031 | 65,928 | $ | (0.06) | $ | (236,867) | 39,219 | $ | (6.04) | $ | (22,573) | 10,006 | $ | (2.26) | ||||||||||||||||||||||
Assumed exchange of shares(3) | (160) | 454 | 7,087 | 21,740 | (8,352) | 42,512 | |||||||||||||||||||||||||||||||
Net income (loss) | 3,871 | (229,780) | (30,925) | ||||||||||||||||||||||||||||||||||
Adjustments to arrive at adjusted | (21,429) | 920 | 296,261 | 2,613 | 52,244 | 2,459 | |||||||||||||||||||||||||||||||
Adjusted net income before taxes | (17,558) | 66,481 | 21,319 | ||||||||||||||||||||||||||||||||||
Adjusted income taxes(5) | 4,460 | (17,019) | (5,458) | ||||||||||||||||||||||||||||||||||
Adjusted net income | $ | (13,098) | 67,302 | (0.19) | $ | 49,462 | 63,572 | $ | 0.78 | $ | 15,861 | 54,977 | $ | 0.29 |
(1) | Reflects the effect of the previously disclosed restatement due to the outstanding warrants being accounted for as liabilities and recorded at fair value. |
(2) | Represents net income attributable to Purple Innovation, Inc. and the associated weighted average diluted shares, of Class A common stock outstanding. |
(3) | Assumes the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period. Also assumes the addition of net income attributable to noncontrolling interests corresponding with the assumed exchange of the Paired Securities for shares of Class A common stock. |
(4) | Represents the total impact of all adjustments identified in the adjusted net income table above to arrive at adjusted income before income taxes. Also assumes the dilutive warrants, options and restricted stock as calculated in accordance with GAAP. |
(5) | Represents the estimated effective tax rate of |
View original content to download multimedia:https://www.prnewswire.com/news-releases/purple-innovation-reports-fourth-quarter-and-full-year-2021-results-board-names-robert-demartini-as-chief-executive-officer-301493285.html
SOURCE Purple Innovation, Inc.
FAQ
What were the Q4 2021 results for Purple Innovation (PRPL)?
Who is the new CEO of Purple Innovation (PRPL)?
What is the revenue forecast for Purple Innovation (PRPL) in 2022?
How did Purple Innovation (PRPL) perform financially in 2021?